Measles, Mumps, and Rubella Booster Immunization Practices
Abstract
Reported cases of mumps infection in the United States (U.S.) have dropped since the introduction of the single-component mumps vaccine in 1967. After introduction of the multi-component measles, mumps, rubella (MMR) vaccine, cases in the U.S. and worldwide fell to the point where the International Task Force for Disease Eradication identified mumps for eventual global eradication. By 1991, all military recruits received an MMR vaccine. By 2010, the Department of Defense (DoD) had adopted a policy of immunizing recruits with MMR vaccine only if their antibody titers to measles or rubella had dropped below threshold levels established by the commercial testing laboratories as indicative of immunity. As part of a 2010 Defense Health Board (DHB) review of MMR immunization practices by the Department of the Navy, the DHB recommended that the Navy continue the practice of MMR immunization based on serosurveillance, but that universal MMR vaccination be re-instituted in the event of an increased risk of a mumps outbreak.
Document Details
- Document Type
- Technical Report
- Publication Date
- May 18, 2020
- Accession Number
- AD1102200
Entities
People
- Alex B Valadka
- Brigid Mccaw
- Craig Blakely
- H. Clifford Lane
- J. T. Armstrong
- Jeremy Lazarus
- John Groopman
- Jonathan M. Friedman
- Karen Guice
- Kathleen Martin
- Lenworth Jr. Jacobs
- Michael Parkinson
- Michael-anne Browne
- Richard Myers
- Robert Kaplan
- Steven Gordon
- Steven Sharfstein
- Vivian Lee
Organizations
- Defense Health Board